Accessibility Menu
Kelyniam Global logo

Kelyniam Global(OTC) KLYG

Market Cap$6.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)-54%
5 Year-21%
1 Year+49%
1 Month-16%
$0.13
-16%
-0.02Today
Kelyniam Global last closing stock price
MetricPriceDate
Last closeUSD 0.132026-07-28
Kelyniam Global stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-11.95%USD 0.142026-07-20
1 month-16%USD 0.152026-06-26
3 month-2.27%USD 0.132026-04-22
Year to date+8.15%USD 0.122025-12-31
1 year+48.94%USD 0.082025-07-28
3 year+70.27%USD 0.072023-07-17
5 year-21.25%USD 0.162021-07-29
Since inception-54.18%USD 0.282008-04-03

Kelyniam Global Financials at a Glance

Market Cap

$6.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.58M

Net Income (TTM)

-$32.62K

EPS (TTM)

-$0.00

P/E Ratio

-210.00

Dividend

$0.00

Beta (Volatility)

0.33 (Low)

Price

$0.13

Volume

1,500

Open

$0.13

Previous Close

$0.13

Daily Range

$0.13 - $0.13

52-Week Range

$0.05 - $0.30

Estimated Earnings Date

N/A

KLYG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kelyniam Global

Kelyniam Global, Inc. is a medical device manufacturer specializing in custom prosthetics and cranial fixation solutions. Established in 2005, the company utilizes advanced computer-aided design and manufacturing processes to deliver high-quality medical products.

Products and Services
  • Custom prosthetics using advanced medical-grade polymers
  • Cranial and craniofacial fixation screws for surgical applications
  • Solutions tailored for health systems, hospitals, and individual patients
Growth Outlook
  • Recent quarterly revenue increased to $1,150,130, a significant rise from previous quarters
  • Gross profit margin improved to 83.4%, indicating efficient cost management
  • Positive cash flow from operations of $175,090 in the latest quarter
Financial Highlights
  • Market capitalization stands at approximately $1.76 million
  • Trailing twelve-month revenue of $3,628,442 reflects steady growth
  • Operating income ratio reached 25.6% in the latest quarter
Kelyniam Global, Inc. operates in the medical devices sector, focusing on innovative solutions for patients with specific needs. The company has demonstrated a commitment to quality and efficiency, as evidenced by its recent financial performance. The increase in quarterly revenue and gross profit margin highlights the effectiveness of its business strategies. With a market capitalization of $1.76 million, Kelyniam Global is positioned for potential growth in the healthcare industry. The positive cash flow from operations further supports the company's financial stability and operational efficiency. Investors may find Kelyniam Global an intriguing opportunity within the medical device market.
AI Generated • Jul 21, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

9

CEO

Ross Bjella

Website

www.kelyniam.com

Headquarters

Canton, CT 06019, US

KLYG Financials

Key Financial Metrics (TTM)

Gross Margin

78.74%

Operating Margin

8.91%

Net Income Margin

-0.91%

Return on Equity

-4.32%

Return on Capital

-8.16%

Return on Assets

-1.68%

Earnings Yield

-0.48%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

50.12M

Volume

1.50K

Avg. Volume

22.39K

Financials (TTM)

Gross Profit

$2.82M

Operating Income

$318.93K

EBITDA

$350.70K

Operating Cash Flow

$83.38K

Capital Expenditure

$0.00

Free Cash Flow

$83.38K

Cash & ST Invst.

$163.33K

Total Debt

$384.66K

Kelyniam Global Performance Analysis

Kelyniam Global annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 3,017,59913.3%
20232023-12-31USD 2,672,357-11.4%
20242024-12-31USD 3,328,38424.5%
20252025-12-31USD 3,053,222-8.3%
Kelyniam Global sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3018.3%
Q32025-09-3011.2%
Q42025-12-315.4%
Q12026-03-3132.7%
Kelyniam Global annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.00N/A
20232023-12-31USD -0.01114.7%
20242024-12-31USD -0.02153.4%
20252025-12-31USD -0.00-84.9%
Kelyniam Global sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30133.3%
Q32025-09-30-400.0%
Q42025-12-31181.8%
Q12026-03-31-144.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$1.15M

+84.0%

Gross Profit

$959.74K

+105.3%

Gross Margin

83.45%

N/A

Market Cap

$6.32MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$701.72K

N/A

Employees

9

N/A

Net Income

-$57.41K

+64.9%

EBITDA

$306.38K

+337.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$163.33K

-10.2%

Total Debt

$384.66K

-28.9%

Accounts Receivable

$530.80K

+61.9%

Inventory

$68.15K

+62.6%

Long Term Debt

$211.69K

-23.8%

Short Term Debt

$172.98K

-34.3%

Return on Assets

-1.68%

N/A

Return on Invested Capital

32.74%

N/A

Free Cash Flow

$175.09K

+271.4%

Operating Cash Flow

$175.09K

+271.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
USAQQHSLab, Inc.
$0.35+0.00%
IGEXIndo Global Exchange(s) PTE, Ltd.
$0.00+0.00%
NUMDNu-Med Plus, Inc.
$0.02+0.00%
CSOCCaduceus Software Systems Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$19.63-0.20%
NOKNokia
$8.41-0.06%
SKHYSK Hynix
$126.79-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About KLYG

What is the current price of Kelyniam Global?

Kelyniam Global is trading at $0.13 per share.

What is the 52-week range for Kelyniam Global?

Over the past 52 weeks, Kelyniam Global has traded between $0.05 and $0.30.

How much debt does Kelyniam Global have?

As of the most recent reporting period, Kelyniam Global reported total debt of $384.66K.

How much cash does Kelyniam Global have on hand?

Kelyniam Global reported $163.33K in cash and cash equivalents in its most recent financial results.

What is Kelyniam Global’s dividend yield?

Kelyniam Global does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services